New Drug Applications Akcea and Ionis Receive Complete Response Letter for Waylivra from FDA 6 years ago
Pharma Industry News FDA approves J&J’s non-chemotherapy combination regimen for rare blood cancer 6 years ago
Pharma Industry News Senate Spending Bills Give Minor Boost to FDA, Seek Price Disclosures in Ads 6 years ago